Media OutReach
Beijing Tong Ren Tang Joins Hands with CMHK Education Platform – Edubile to Launch Inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care
“Inheriting Traditional Chinese Medicine, Inspiring a Smarter Future”
HONG KONG SAR – Media OutReach Newswire – 25 March 2025 – Beijing Tong Ren Tang has a brand history spanning over 350 years. Beijing Tong Ren Tang Chinese Medicine Company Limited (“Beijing Tong Ren Tang”) (3613.HK) in Hong Kong is committed to promoting the legacy of traditional Chinese medicine culture and supporting the industry’s long-term development. Recently, the company held a Plaque Cleansing (Complimenting) Ceremony at its Research and Development Production Plant at Tai Po Industrial Estate to celebrate the annual global “Tong Ren Tang Day,” reaffirming its commitment to uphold virtues, nurture culture, and sustain traditional craftsmanship. Today, Beijing Tong Ren Tang officially announced its series of activities for 2025, highlighting the inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care.”
The “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” is organized by Beijing Tong Ren Tang and supported by China Mobile Hong Kong Company Limited (“CMHK”) through its education platform “Edubile”. The programme combines Tong Ren Tang’s over 350 years of traditional Chinese medicine wisdom with Edubile’s 5G+AIoT technologies, providing participating schools with a specially designed course named “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course” that integrates STEAM education elements. The course aims to fuel Hong Kong students’ interest in traditional Chinese medicine culture and modern technology. It also seeks to enhance their awareness of career planning, nurture a new generation of student ambassadors promoting traditional Chinese medicine culture, and actively contribute to the development of community health.
Today, Beijing Tong Ren Tang held a launch ceremony for the inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” at its Research and Development Production Plant at Tai Po Industrial Estate. Distinguished officiating guests included Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Liu Gang, Factory Manager of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Chen Ning Jie, Assistant General Manager, Product Centre, China Mobile Hong Kong Company Limited, and Mr. Wong Wai Lung, Senior Product Manager (Education Product), China Mobile Hong Kong Company Limited.
Speaking at the ceremony, Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited, said, “With a brand history of over 350 years, Beijing Tong Ren Tang is dedicated to passing on the essence and wisdom of traditional Chinese medicine to benefit society and the world. We are thrilled to be supported by China Mobile Hong Kong’s education platform Edubile. By integrating the knowledge of traditional Chinese medicine with smart and innovative technologies, we bring a wealth of diverse experiences to campus for teachers and students. Our goal is to deepen public understanding, preserve this rich cultural heritage, and promote healthier lifestyles.”
Mr. Chen Ning Jie, Assistant General Manager, Product Centre at China Mobile Hong Kong Company Limited, stated that CMHK was honored to collaborate with Beijing Tong Ren Tang through Edubile, jointly promoting the convergence of culture, education, and technology while proactively nurturing the next generation of talent. He mentioned that by leveraging CMHK Edubile’s proprietary 5G+AIoT technologies, they provided students with immersive and interactive learning experiences, which included cultivating and observing the growth cycles of Chinese medical herbs. Such an approach would inspire students’ research spirit and creative thinking. Mr. Chen expressed that China Mobile Hong Kong looked forward to working closely with Beijing Tong Ren Tang to create a new landscape in education.
The inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” offers the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course,” covering four major areas: theoretical knowledge, practical experiments, expert interactive learning, and community engagement. The course provides in-depth knowledge of Chinese medical herb cultivation techniques, medicinal herb knowledge, and modern developments in Chinese medicine. It also includes practical components, such as making Chinese medicine herbal sachets, to enhance enjoyment and stimulate student participation.
Through the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course” students will learn to cultivate various types of Chinese medicinal herbs, utilizing CMHK Edubile’s 5G+AIoT technologies to observe, record, and analyze plant growth data. Participants will also have the unique opportunity to visit Beijing Tong Ren Tang’s Research and Development Production Plant and Cultural Museum at Tai Po Industrial Estate, as well as CMHK 5G Lab, interacting and exchanging insights with traditional Chinese medicine experts and technology specialists. This experience enhances students’ understanding of the Chinese medicine industry and its technological applications. The comprehensive program fosters awareness of traditional Chinese medicine culture, inspires interest in its practices, and encourages creative thinking through practical experiences, achieving interdisciplinary educational innovation.
The “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” is now open for enrolment for local primary and secondary school students. Upon completion of the course and community activities, participants will be awarded the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course” Certificate and become “Hong Kong Student Ambassador for Chinese Medicine and Health Care”. For more details and enrolment information, please contact the programme coordinator via email at [email protected] on or before 30 March 2025.Hashtag: #BeijingTongRenTang #Edubile #ChineseMedicine #StudentAmbassador #Education #SmartGreen
https://cm.tongrentang.com
https://www.facebook.com/beijingtongrentanghk
The issuer is solely responsible for the content of this announcement.
About Tong Ren Tang Day
On the 18th day of the second lunar month in the year 1723 (during the reign of Emperor Yongzheng), the Imperial Medical Bureau official, Liu Shengfang, submitted the memorial to the throne. Emperor Yongzheng approved the supply of medicinal materials from the Tong Ren Tang pharmacy for use in the Imperial Palace. This marked the beginning of a unique 188-year tradition of providing medicinal supplies to the Qing dynasty palace. As a result, the 18th day of the second lunar month was designated as ‘Tong Ren Tang Day’.
About Beijing Tong Ren Tang
Tong Ren Tang was founded in 1669, and has a history of 356 years. The company has always adhered to its corporate motto of “No compromise on cost and labour despite the complexity of processing herbal medicine. No compromise on quality and standard despite the scarcity of medicine ingredients.” This commitment has led Beijing Tong Ren Tang to steady development, lasting through every generation, achieving excellence, and becoming a national treasure while expanding globally.
At the same time, Beijing Tong Ren Tang has taken on the mission of promoting traditional Chinese medicine culture, actively participating in domestic and international traditional Chinese medicine promotion activities, facilitating cultural exchanges around the world, and striving to expand the international influence of traditional Chinese medicine. To date, it has been operating over 160 retail branches in 26 countries and regions overseas, making it one of the most recognized traditional Chinese medicine brands internationally.
About Beijing Tong Ren Tang Chinese Medicine Company Limited
In 2004, Tong Ren Tang expanded its operations overseas by establishing Beijing Tong Ren Tong Chinese Medicine Company Limited in Hong Kong. Ahering to the corporate belief of “Nurturing kindness and virture, Preserving tranquility and wellness”, and with the mission of “Healthy Life, Globally Choice”, the company is based in Hong Kong while strategically positioning itself worldwide. It carries the mission of promoting traditional Chinese medicine culture outside mainland China. By employing a model that integrates medical services with medicine and emphasizes cultural outreach, the company is driving forward the internationalization of traditional Chinese medicine. (Beijing Tong Ren Tong Chinese Medicine Company Limited website: https://cm.tongrentang.com)
About New Product Research and Development
Beijing Tong Ren Tang Chinese Medicine Company Limited actively develops a variety of registered Traditional Chinese patent medicines and health products, embodying the philosophy of “Health Life, Globally Choice.” This year, the company has introduced a registered Chinese medicine specifically designed for the prevention and treatment of non-alcoholic fatty liver disease (NAFLD) – Lingzhi Jianghuang Fufang Huoxue Anshen Capsules, which includes Ganoderma and turmeric compound for invigorating qi and tranquilizing the mind.. This product features a unique formula containing ingredients such as Ganoderma, turmeric, magnolia berry, and , and kudzu root. It offers a range of benefits, including promoting blood circulation and energy flow, quenching thirst, replenishing energy, and calming the mind. With its “cleanse, regulate, and nourish” three-in-one functionality, the product can reduce visceral fat, harmonize the body, and ultimately repair and protect the liver. Last year, the company’s research and development team collaborated with one of the local well-known universities on the “Pharmacodynamic and mechanism study of Lingzhi-Jianghuang Formula (LJF) extract on NAFLD in mice” was funded by Hong Kong Research Grants Council under Research Matching Grant Scheme. It is a strongly supportive study for the product’s efficacy. Furthermore, the company has created awide range of high-quality health products to comprehensively care for public health.
About Edubile
In support of the Hong Kong SAR Government’s strategic direction in nurturing technological talent, China Mobile Hong Kong (CMHK) has launched its education platflorm “Edubile”. Drawing on its strengths in 5G and AI technologies, Edubile aims to drive digital transformation across campuses, fostering a new generation of innovation and technology leaders. Guided by its vision of “Bringing 5G+AI Technology into Campuses”, Edubile has developed speciialised educational content and e-learning platforms for educational purposes. By integrating advanced 5G networks with smart campus applications, the initiative significantly enhances school management efficiency and teaching quality, facilitating comprehensive improvements in both teaching methodologies and administrative processes.
Additionally, Edubile has introduced Hong Kong’s first-ever “5G+Green Technology” course, entitled “Smart Green Campus”. This pioneering programme combines 5G technology, the Internet of Things (IoT), and artificial intelligence to assist teachers and students in collaboratively designing campus-based Chinese medicinal gardens and environmentally friendly gardens. The curriculum not only deepens students’ appreciation of traditional Chinese medicine culture but also cultivates their environmental awareness and innovative thinking through practical technological applications, achieving interdisciplinary educational innovation.
Looking forward, China Mobile Hong Kong will continue to deepen the integration of 5G+AI technologies with innovation and technology education. Through organising diverse educational activities and developing advanced smart educational solutions, CMHK is committed to supporting the creation of a sustainable technology education ecosystem in Hong Kong, nurturing digitally competitive talent for the society of tomorrow.
About China Mobile Hong Kong Limited
China Mobile Hong Kong Company Limited (“CMHK”) is the wholly-owned subsidiary of China Mobile Limited (HKEx: 941), which is listed on the Fortune Global 500. CMHK was incepted in January 1997 and was the first mobile network operator to launch PCS services in Hong Kong.
As the world’s leading mobile network brand with the largest customer base*, The Company offers innovative and comprehensive communications services, including voice, data, IDD and international roaming through 5G, 4G LTE and 3GHSPA and other technologies. The Company is committed to the development of 5G with new technologies such as artificial intelligence, internet of things, cloud computing and big data, integrating 5G applications in different industries, promoting the construction and development of smart city groups in Greater Bay Area.
*China Mobile (Hong Kong) Limited is a wholly-owned subsidiary of China Mobile Limited. As of 31 December 2023, China Mobile Limited had the largest number of mobile network subscribers in the world.
Media OutReach
St. George’s University Prepares Future South Korean Physicians for the Growing Global Cancer Care Challenge
Recognizing the importance of addressing workforce shortage in South Korea, St. George’s University (SGU) School of Medicine in Grenada, West Indies, highlights how its medical education approach supports the development of clinical competencies relevant to cancer care across healthcare settings.
These challenges reflect broader global trends, where cancer care increasingly depends on multidisciplinary teams rather than specialty expansion alone. SGU’s curriculum is designed to build a strong foundation in clinical diagnosis, patient communication and multidisciplinary care, which are essential skills for effective oncology and cancer-related care. Through anatomy labs, simulation-based learning, and integrated digital tools, students develop foundational clinical skills in structured, supervised environments designed to reflect real-world medical practice.
The curriculum also integrates traditional cadaveric dissection with modern 3D anatomical modeling. This blend helps students visualize the human body in a holistic way while reinforcing knowledge through their hands-on interaction. SGU’s simulation lab also enables medical students to have their first direct interaction with ill patients in a safe, simulated learning environment.
On top of core medical training, SGU offers early exposure to prevention, diagnosis and patient-centered care to prepare graduates to tackle complex health issues. SGU has developed long-standing relationships with more than 75 established hospitals and clinical centers in the US and UK. These clinical placements provide exposure to diverse patient populations and care environments, including settings where cancer diagnosis and management are part of routine clinical practice.
South Korean SGU alumni are contributing to healthcare systems through roles that intersect with cancer diagnosis, treatment coordination, and long-term patient care. For example, Dr. Julia Hweyryoung Cho, MD 2022 is practicing internal medicine, which plays a crucial role in cancer care. Internal medicine physicians are often involved in the initial diagnosis of cancer, managing complex medical conditions that may arise during treatment and providing long-term comprehensive care and survivorship planning for patients with a history of cancer.
In observance of World Cancer Day 2026, SGU encourages all medical professionals and organizations to collaboratively address global cancer care challenges. This includes recognizing and meeting the cancer healthcare needs of individuals and communities in South Korea.
For more information on the programs and tracks available through SGU School of Medicine, visit SGU’s website.Hashtag: #St.George’sUniversity
The issuer is solely responsible for the content of this announcement.
Media OutReach
Finalists and Semifinalists for $1 Million Seeding The Future Global Food System Challenge Announced
Created and funded by Seeding The Future Foundation and, for the first time, hosted by Welthungerhilfe (WHH), the Challenge attracted a record 1,600+ applications from innovator teams in 112 countries, underscoring growing global momentum for food systems transformation.
Following a multi-stage, rigorous international review process, 36 teams have advanced across three award levels. These include 16 Seed Grant Finalists (competing for 8 awards of USD 25,000), 12 Growth Grant Semifinalists (competing for 3 awards of USD 100,000), and 8 Seeding The Future Grand Prize Semifinalists (competing for 2 awards of USD 250,000).
“Hosting the GFSC reflects Welthungerhilfe’s commitment to accelerating bold, scalable innovations where they are needed most. This year’s diversity of solutions underscores the complexity of food system challenges and the creativity of innovators worldwide.” said Jan Kever, Head of Innovation at Welthungerhilfe
The submitted innovations span diverse themes and approaches, including climate-smart production, nutrient-dense foods, food loss reduction, and inclusive market models, reflecting the complexity and interconnected nature of today’s food systems challenges.
“The Seeding The Future Global Food System Challenge exists to catalyze impactful, bold, and scalable innovations that advance food systems transformation. We are excited to work alongside Welthungerhilfe as a trusted partner and host of the Challenge and are encouraged by the quality and diversity of innovations emerging from this first year of collaboration.” said Bernhard van Lengerich, Founder and CEO of Seeding The Future Foundation
While the number of awards is limited, all semifinalists and finalist applicants plus all applicants with any prior recognition of other innovation competitions can join the STF Global Food System Innovation Database and Network—currently in beta testing with the Food and Agriculture Organization of the United Nations—vastly expanding their visibility and reach across a global audience.
List of 2025 GFSC Seed Grant Finalists, Growth Grant and Seeding The Future Grand Prize Semifinalists
Find details here: welthungerhilfe.org/gfsc-finalists
Seeding The Future Grand Prize Semi-Finalists
- CNF Global, Kenya
- ZTN Technology PLC, Ethiopia
- One Acre Fund, Rwanda
- Sanku, Tanzania
- Nabahya Food Institute (NFI), Democratic Republic of the Congo
- ABALOBI, South Africa
- metaBIX Biotech, Uruguay
- Nurture Posterity International, Uganda
Growth Grant Semi-Finalists
- Baobaby, Togo
- Safi International Technologies Inc., Canada
- Centro Internacional de Mejoramiento de Maíz y Trigo (CIMMYT), Mexico
- Farmlab Yeranda Agrisolution Producer Company Limited, India
- Banco de Alimentos Santa Fe (BASFE), Argentina
- Chartered Consilorum (Pty) Ltd, South Africa
- American University of Beirut, Environment and Sustainable Development Unit (ESDU at AUB), Lebanon
- The Source Plus, Kenya
- Iviani Farm Limited, Kenya
- Rwandese Endogenous Development Association, Rwanda
- NatureLEAD, Madagascar
- Ndaloh Heritage Organisation, Kenya
Seed Grant Finalists
- Inua Damsite CBO, Kenya
- World Neighbors, United States
- Keloks Technologies Ltd, Nigeria
- REBUS Albania, Albania
- Tanzania Conservation and Community Empowerment Initiative (TACCEI), Tanzania
- Intrasect, Switzerland
- VKS AGRITECH, India
- Murmushi People’s Development Foundation, Nigeria
- Levo International, Inc., United States
- Effective Altruism Research Services Ltd, Uganda
- Taita Taveta University, Kenya
- CultivaHub, Democratic Republic of the Congo
- Resource Hub for Development (RHD), Kenya
- FUTURALGA S.COOP.AND, Spain
- West Africa Centre for Crop Improvement, University of Ghana, Ghana
- Sustainable Solutions Kenya, Kenya
Hashtag: #TheFutureGlobalFoodSystemChallenge
The issuer is solely responsible for the content of this announcement.
About Seeding The Future Foundation
STF is a private nonprofit dedicated to ensuring equitable access to safe, nutritious, affordable, and trusted food. It supports innovations that transform food systems and benefit both people and planet. More at Seeding the future.
About Welthungerhilfe
WHH is one of Germany’s largest private aid organizations, striving for a world without hunger since 1962. More at: Welthungerhilfe (WHH)
Media OutReach
PolyU develops novel antibody targeting fat cell protein, offering new approach to treating metabolism-related liver cancer
Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly known as fatty liver disease, currently affects around a quarter of the global population and is an important risk factor for liver cancer. In affected individuals, fat cells induce insulin resistance and chronic inflammation, leading to excessive fat accumulation in the liver. This ultimately impairs liver function and may progress to liver cancer. Treatment options for MASLD-induced liver cancer remain limited and the effectiveness of current immunotherapies is suboptimal.
A breakthrough study led by Prof. Terence LEE, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology, and his research team has revealed that an adipocyte-derived protein, known as fatty acid-binding protein 4 (FABP4) is a key driver that accelerates tumour growth. Through mass spectrometry, the team confirmed that patients with MASLD-induced liver cancer had markedly elevated FABP4 levels in their serum. Further investigations showed that FABP4 activates a series of pro-proliferative signalling pathways within cells, causing cancer cells to multiply and grow more rapidly.
Prof. Lee’s team has successfully developed a monoclonal antibody that neutralises FABP4. This antibody not only inhibits the growth and proliferation of FABP4-driven cancer stem cells, but also enhances the ability of immune cells to combat cancer.
Prof. Lee said, “This neutralising antibody against FABP4 demonstrates significant potential in inhibiting tumour growth and activating immune cells, providing a complementary approach to current immunotherapy strategies. Our findings highlight that targeting adipocyte-derived FABP4 holds promise for treating MASLD-induced liver cancer.”
Prof. Lee added that gaining deeper insights into how adipocyte-derived FABP4 affects liver cancer cells helps to explicate the disease mechanisms of liver cancer, particularly in obese individuals. Intervening in the relevant signalling pathways could provide effective methods to combat this aggressive malignancy.
Prof. Lee believes that, as this adipocyte-targeted immunotherapy continues to mature, it will bring more treatment options to MASLD patients. He remarked, “If its efficacy can be proven in clinical trials, it could offer new hope to many affected individuals.”
The research is supported by the Innovation and Technology Fund of the Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China. PolyU has filed a non-provisional patent for the developed antibody and is continuing to optimise its binding affinity to facilitate future clinical applications.
Hashtag: #PolyU #FattyLiver #Cancer #LiverCancer #理大 #香港理工大学 #肝癌 #癌症 #脂肪肝
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn